US · Healthcare · Health Information Services
EPS came in at 1.04 against a street estimate of 0.99 — a beat of 5.1%.
Analysts rate HealthEquity Inc a strong buy (13 buy, 1 hold, 0 sell out of 14) with an average price target of $119.00.
CONFIDENT HealthEquity reported accelerated 8% revenue growth, record 48% adjusted EBITDA margin, and 10.7M HSA accounts. Raised FY2027 guidance. Marketplace and investing engagement surging; AI-driven cost reductions enabling margin expansion. Q2 FY2027 Analysts probed marketplace monetization (early but encouraging signals), margin runway (member-side gains evident; client/back-office upside ahead), and distribution mix (balanced hybrid). Management highlighted early learnings on app UI, Health Savings Days success, and continued AI application across workflows. 2026-08-27…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.73% |
| Wasatch Advisors LP | 9.62% |
| Vanguard Portfolio Management, LLC | 5.03% |
| Vanguard Capital Management, LLC | 4.62% |
| State Street Corp | 3.75% |
| Morgan Stanley - Brokerage Accounts | 3.01% |
| Geode Capital Management, LLC | 2.73% |
| AQR Capital Management LLC | 2.53% |
| Document | Date |
|---|---|
| Quarterly report · Q2 FY2027 HEALTHEQUITY, INC. - 10-Q SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total Revenue (6 months ended July 31, 2026): $705.4 million, up from $656 | 2026-08-27 |
| Results announced · Q3 FY2027 HEALTHEQUITY, INC. – Q2 FY2027 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue: $350.7 million, up 8% YoY ($325.8 million in Q2 FY2026) • Net Income: $6 | 2026-08-27 |
| Shareholder vote results · Q2 FY2027 HEALTHEQUITY, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company held 2026 Annual Meeting on June 25, 2026 • 83,830,457 shares of common stock issue | 2026-06-26 |
| Quarterly report · Q1 FY2027 HEALTHEQUITY, INC. - Q1 FY2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue: $354.6 million (Q1 2026) vs. $330.8 million (Q1 2025) — 7.2% increase | 2026-05-28 |
| Results announced · Q2 FY2027 HEALTHEQUITY Q1 FY2027 EARNINGS SUMMARY HEADLINE NUMBERS • Net income increased 29% to $69.4 million with net income margin expanding to 20% from 16 | 2026-05-28 |
| Proxy statement · Q4 FY2026 HEALTHEQUITY, INC. PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect ten directors to serve until 2027 annual meeting (maj | 2026-05-13 |
| Board / officer change · Q2 FY2027 HEALTHEQUITY, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial metrics or operational performance data disclosed in this filing • Document is | 2026-05-08 |
| Annual report FY2026 HEALTHEQUITY, INC. - FORM 10-K SUMMARY Fiscal Year Ended January 31, 2026 --- HEADLINE NUMBERS • Total Accounts Administered: 17.8 million (10.6 mi | 2026-03-17 |
Readable in the app.
| Announcement | Date |
|---|---|
| Initial outlook for fiscal 2027 and reaffirmed fiscal 2026 guidance HealthEquity, Inc. issued a press release on January 12, 2026, providing initial financial guidance for its fiscal year ending January 31, 2027, while reaffirming guidance for the fiscal yea | 2026-01-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for HealthEquity Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.